Filing Details
- Accession Number:
- 0001225208-14-019233
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-08-28 18:27:31
- Reporting Period:
- 2014-08-27
- Filing Date:
- 2014-08-28
- Accepted Time:
- 2014-08-28 18:27:31
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1099800 | Edwards Lifesciences Corp | EW | Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842) | 364316614 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1440664 | D Carlyn Solomon | One Edwards Way Irvine CA 92614 | Cvp, Critical Care & Vascular | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2014-08-27 | 85,200 | $50.96 | 116,354 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2014-08-27 | 3,212 | $98.53 | 113,142 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2014-08-27 | 81,988 | $97.83 | 31,154 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Employee Stock Option (Right to Acquire) | Disposition | 2014-08-27 | 85,200 | $0.00 | 85,200 | $50.96 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2011-05-13 | 2017-05-12 | No | 4 | M | Direct |
Footnotes
- This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the reporting person.
- This transaction was executed in multiple trades at prices ranging from $98.4515 to $98.78. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $97.46 to $98.45. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected.
Billionaire Hedge Funds
